Dark biotechnology, often referred to as "black biotechnology," encompasses the application of biotechnological processes to develop products or technologies with potentially harmful or controversial implications. Unlike its counterparts in white and red biotechnology, which focus on medical and industrial applications, dark biotechnology delves into areas that raise ethical concerns. This field includes activities such as bio-warfare research, bioterrorism, and the creation of biological weapons. The manipulation of living organisms for destructive purposes has sparked debates about the ethical boundaries and the need for stringent regulations to prevent the misuse of scientific advancements. The ethical considerations surrounding dark biotechnology highlight the importance of responsible research practices and global cooperation to mitigate the potential risks associated with these controversial applications.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Advancement in dual lateral flow immunoassay design for sensitive, rapid detection of rotavirus and adenovirus in stool samples
Ayan Ahmed Isse, Genexus Biotech Company, Somalia
Title :
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Diversity analyses of microbial communities in Armanis gold-polymetallic mine and acid mine drainage: Bioremediation
Anna Khachatryan, SPC Armbiotechnology of NAS of Armenia, Armenia